RV: Treatment of AMD: How have we come here, what is next? (341)

Session type

Special Interest Symposium

Date, time and place

Sunday, August 26, 2012 at 15:30-17:00 in Finland


Immonen I


From MPS to VIEW and CATT, the large multicenter studies have guided our treatment choices in AMD. The questions that each of these studies has answered and left unanswered are reviewed. Is off-label anti-VEGF treatment less effective or dangerous? Can we treat dry AMD? These topics are reviewed in this symposium.

Abstracts assigned